02 Dec Pharmazac launched the new product Cinacalcet
Pharmazac launched the new product Cinacalcet 30-60 and 90mg in F.C.Tablets. Cinacalcet indicated for the treatment of secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. Hypercalemia in adults patients with Parathyroid Carcinoma (PC) and Hypercalemia in adults patient with primary (HPT) for whom Parathyroid ectomy would be indicated on basis of serum calcium levels, but who are unable to undergo parathyroidectomy.